Thyroid Disorder Market by Disorderand Application- Global Industry Analysis & Forecast to 2027
Published On : October 2020 Pages : 152 Category: Pharma & Healthcare Report Code : HC1013320
Thyroid Disorder Market By Disorder (Hypothyroidism, Hyperthyroidism) and Distribution Channel (Wholesaler/Distributors, Retail Chain, Online Distribution, Others)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Thyroid Disorder Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Hyperthyroidism, occurs when the thyroid gland is overactive and produces too much of its hormone, while Hypothyroidism occurs when the thyroid gland is underactive, and it can’t produce enough of its hormones. Treatment involves theblood test that measures the levels of thyroid hormone (thyroxine, or T4) and thyroid-stimulating hormone (TSH) in the blood.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Thyroid Disorder Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott
- Pfizer
- Lannett Company, Inc.
- GlaxoSmithKline
- Merck KGaA
- Mylan N.V.
- AbbVie Inc.
- Amgen
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Thyroid Disorder Market, ByDisorder Type, Estimates and Forecast, 2017-2027 ($Million)
o Hypothyroidism
o Hyperthyroidism
· Thyroid Disorder Market, ByDistribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Wholesaler/Distributors
o Retail Chain
o Online Distribution
o Others
· Thyroid Disorder Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott
o Pfizer
o Lannett Company, Inc.
o GlaxoSmithKline
o Merck KGaA
o Mylan N.V.
o AbbVie Inc.
· Thyroid Disorder Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Thyroid Disorder Market, By Country
o U.S. Thyroid Disorder Market
o Canada Thyroid Disorder Market
o Mexico Thyroid Disorder Market
o Europe
§ Europe Thyroid Disorder Market, By Country
o UK Thyroid Disorder Market
o Germany Thyroid Disorder Market
o France Thyroid Disorder Market
o Russia Thyroid Disorder Market
o Italy Thyroid Disorder Market
o Rest of Europe Thyroid Disorder Market
o Asia-Pacific
§ Asia-Pacific Thyroid Disorder Market, By Country
o China Thyroid Disorder Market
o Japan Thyroid Disorder Market
o South Korea Thyroid Disorder Market
o India Thyroid Disorder Market
o Southeast Asia Thyroid Disorder Market
o Rest of Asia-Pacific Thyroid Disorder Market
o South America
§ South America Thyroid Disorder Market
o Brazil Thyroid Disorder Market
o Argentina Thyroid Disorder Market
o Columbia Thyroid Disorder Market
o Rest of South America Thyroid Disorder Market
o Middle East and Africa
§ Middle East and Africa Thyroid Disorder Market
o Saudi Arabia Thyroid Disorder Market
o UAE Thyroid Disorder Market
o Egypt Thyroid Disorder Market
o Nigeria Thyroid Disorder Market
o South Africa Thyroid Disorder Market
o TurkeyThyroid Disorder Market
o Rest of MEA Thyroid Disorder Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Thyroid Disorder Market, By Disorder Type
5.1. Introduction
5.2. Global Thyroid Disorder Revenue and Market Share by Disorder Type (2017-2021)
5.2.1. Global Thyroid Disorder Revenue and Revenue Share by Disorder Type (2017-2021)
5.3. Hypothyroidism
5.3.1. Global Hypothyroidism Revenue and Growth Rate (2017-2021)
5.4. Hyperthyroidism
5.4.1. Global Hyperthyroidism Revenue and Growth Rate (2017-2021)
6. Thyroid Disorder Market, By Distribution Channel
6.1. Introduction
6.2. Global Thyroid Disorder Revenue and Market Share by Distribution Channel (2017-2021)
6.2.1. Global Thyroid Disorder Revenue and Revenue Share by Distribution Channel (2017-2021)
6.3. Wholesaler/Distributors
6.3.1. Global Wholesaler/Distributors Revenue and Growth Rate (2017-2021)
6.4. Retail Chain
6.4.1. Global Retail Chain Revenue and Growth Rate (2017-2021)
6.5. Online Distribution
6.5.1. Global Online Distribution Revenue and Growth Rate (2017-2021)
6.6. Others
6.6.1. Global Others Revenue and Growth Rate (2017-2021)
7. Thyroid Disorder Market, By Region
7.1. Introduction
7.2. Global Thyroid Disorder Revenue and Market Share by Regions
7.2.1. Global Thyroid Disorder Revenue by Regions (2017-2021)
7.3. North America Thyroid Disorder by Countries
7.3.1. North America Thyroid Disorder Revenue and Growth Rate (2017-2021)
7.3.2. North America Thyroid Disorder Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Thyroid Disorder by Countries
7.4.1. Europe Thyroid Disorder Revenue and Growth Rate (2017-2021)
7.4.2. Europe Thyroid Disorder Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Thyroid Disorder by Countries
7.5.1. Asia-Pacific Thyroid Disorder Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Thyroid Disorder Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Thyroid Disorder by Countries
7.6.1. South America Thyroid Disorder Revenue and Growth Rate (2017-2021)
7.6.2. South America Thyroid Disorder Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Thyroid Disorder by Countries
7.7.1. Middle East and Africa Thyroid Disorder Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Thyroid Disorder Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Abbott
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Pfizer
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Lannett Company, Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. GlaxoSmithKline
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Merck KGaA
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Mylan N.V.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. AbbVie Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Amgen
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Thyroid Disorder Market Forecast (2022-2027)
9.1. Global Thyroid Disorder Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Thyroid Disorder Market Forecast by Regions (2022-2027)
9.2.1. North America Thyroid Disorder Market Forecast (2022-2027)
9.2.1.1. United States Thyroid Disorder Market Forecast (2022-2027)
9.2.1.2. Canada Thyroid Disorder Market Forecast (2022-2027)
9.2.1.3. Mexico Thyroid Disorder Market Forecast (2022-2027)
9.2.2. Europe Thyroid Disorder Market Forecast (2022-2027)
9.2.2.1. Germany Thyroid Disorder Market Forecast (2022-2027)
9.2.2.2. France Thyroid Disorder Market Forecast (2022-2027)
9.2.2.3. UK Thyroid Disorder Market Forecast (2022-2027)
9.2.2.4. Russia Thyroid Disorder Market Forecast (2022-2027)
9.2.2.5. Italy Thyroid Disorder Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Thyroid Disorder Market Forecast (2022-2027)
9.2.3. Asia-Pacific Thyroid Disorder Market Forecast (2022-2027)
9.2.3.1. China Thyroid Disorder Market Forecast (2022-2027)
9.2.3.2. Japan Thyroid Disorder Market Forecast (2022-2027)
9.2.3.3. Korea Thyroid Disorder Market Forecast (2022-2027)
9.2.3.4. India Thyroid Disorder Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Thyroid Disorder Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Thyroid Disorder Market Forecast (2022-2027)
9.2.4. South America Thyroid Disorder Market Forecast (2022-2027)
9.2.4.1. Brazil Thyroid Disorder Market Forecast (2022-2027)
9.2.4.2. Argentina Thyroid Disorder Market Forecast (2022-2027)
9.2.4.3. Columbia Thyroid Disorder Market Forecast (2022-2027)
9.2.4.4. Rest of South America Thyroid Disorder Market Forecast (2022-2027)
9.2.5. Middle East and Africa Thyroid Disorder Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Thyroid Disorder Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Thyroid Disorder Market Forecast (2022-2027)
9.2.5.3. Egypt Thyroid Disorder Market Forecast (2022-2027)
9.2.5.4. Nigeria Thyroid Disorder Market Forecast (2022-2027)
9.2.5.5. South Africa Thyroid Disorder Market Forecast (2022-2027)
9.2.5.6. Turkey Thyroid Disorder Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Thyroid Disorder Market Forecast (2022-2027)
9.3. Thyroid Disorder Market Forecast by Disorder Type (2022-2027)
9.3.1. Thyroid Disorder Forecast by Disorder Type (2022-2027)
9.3.2. Thyroid Disorder Market Share Forecast by Disorder Type (2022-2027)
9.4. Thyroid Disorder Market Forecast by Distribution Channel (2022-2027)
9.4.1. Thyroid Disorder Forecast by Distribution Channel (2022-2027)
9.4.2. Thyroid Disorder Market Share Forecast by Distribution Channel (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Thyroid Disorder Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Thyroid Disorder Revenue and Revenue Share by Disorder Type (2017-2019)
Figure Global Hypothyroidism Revenue and Growth Rate (2017-2019)
Figure Global Hyperthyroidism Revenue and Growth Rate (2017-2019)
Table Global Thyroid Disorder Revenue and Revenue Share by Distribution Channel (2017-2019)
Figure Global Wholesaler/Distributors Revenue and Growth Rate (2017-2019)
Figure Global Retail Chain Revenue and Growth Rate (2017-2019)
Figure Global Online Distribution Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Thyroid Disorder Revenue by Regions (2017-2019)
Figure North America Thyroid Disorder Growth Rate (2017-2019)
Figure North America Thyroid Disorder Revenue and Growth Rate (2017-2019)
Figure North America Thyroid Disorder by Countries (2017-2019)
Figure North America Thyroid Disorder Revenue (Million USD) by Countries (2017-2019)
Figure United States Thyroid Disorder Growth Rate (2017-2019)
Figure United States Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Thyroid Disorder Growth Rate (2017-2019)
Figure Canada Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Thyroid Disorder Growth Rate (2017-2019)
Figure Mexico Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Thyroid Disorder Growth Rate (2017-2019)
Figure Europe Thyroid Disorder Revenue and Growth Rate (2017-2019)
Figure Europe Thyroid Disorder by Countries (2017-2019)
Figure Europe Thyroid Disorder Revenue (Million USD) by Countries (2017-2019)
Figure Germany Thyroid Disorder Growth Rate (2017-2019)
Figure Germany Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Thyroid Disorder Growth Rate (2017-2019)
Figure France Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Thyroid Disorder Growth Rate (2017-2019)
Figure UK Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Thyroid Disorder Growth Rate (2017-2019)
Figure Russia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Thyroid Disorder Growth Rate (2017-2019)
Figure Italy Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Thyroid Disorder Growth Rate (2017-2019)
Figure Rest of Europe Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Thyroid Disorder Growth Rate (2017-2019)
Figure Asia-Pacific Thyroid Disorder Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Thyroid Disorder by Countries (2017-2019)
Figure Asia-Pacific Thyroid Disorder Revenue (Million USD) by Countries (2017-2019)
Figure China Thyroid Disorder Growth Rate (2017-2019)
Figure China Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Thyroid Disorder Growth Rate (2017-2019)
Figure Japan Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Thyroid Disorder Growth Rate (2017-2019)
Figure Korea Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Thyroid Disorder Growth Rate (2017-2019)
Figure India Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Thyroid Disorder Growth Rate (2017-2019)
Figure Southeast Asia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Thyroid Disorder Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Thyroid Disorder Growth Rate (2017-2019)
Figure South America Thyroid Disorder Revenue and Growth Rate (2017-2019)
Figure South America Thyroid Disorder by Countries (2017-2019)
Figure South America Thyroid Disorder Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Thyroid Disorder Growth Rate (2017-2019)
Figure Brazil Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Thyroid Disorder Growth Rate (2017-2019)
Figure Argentina Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Thyroid Disorder Growth Rate (2017-2019)
Figure Columbia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Thyroid Disorder Growth Rate (2017-2019)
Figure Rest of South America Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Thyroid Disorder Growth Rate (2017-2019)
Figure Middle East and Africa Thyroid Disorder Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Thyroid Disorder by Countries (2017-2019)
Figure Middle East and Africa Thyroid Disorder Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Thyroid Disorder Growth Rate (2017-2019)
Figure Saudi Arabia Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Thyroid Disorder Growth Rate (2017-2019)
Figure United Arab Emirates Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Thyroid Disorder Growth Rate (2017-2019)
Figure Egypt Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Thyroid Disorder Growth Rate (2017-2019)
Figure Nigeria Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Thyroid Disorder Growth Rate (2017-2019)
Figure South Africa Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Thyroid Disorder Growth Rate (2017-2019)
Figure Turkey Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Thyroid Disorder Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Thyroid Disorder Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott Thyroid Disorder Financial Overview
Table Pfizer Thyroid Disorder Financial Overview
Table Lannett Company, Inc. Thyroid Disorder Financial Overview
Table GlaxoSmithKline Thyroid Disorder Financial Overview
Table Merck KGaA Thyroid Disorder Financial Overview
Table Mylan N.V. Thyroid Disorder Financial Overview
Table AbbVie Inc. Thyroid Disorder Financial Overview
Table Amgen Thyroid Disorder Financial Overview
Figure Global Thyroid Disorder Revenue (Millions USD) and Growth Rate (2019-2027)
Table Thyroid Disorder Market Forecast by Regions (2019-2027)
Figure North America Thyroid Disorder Market Forecast (2019-2027)
Figure United States Thyroid Disorder Market Forecast (2019-2027)
Figure Canada Thyroid Disorder Market Forecast (2019-2027)
Figure Mexico Thyroid Disorder Market Forecast (2019-2027)
Figure Europe Thyroid Disorder Market Forecast (2019-2027)
Figure Germany Thyroid Disorder Market Forecast (2019-2027)
Figure France Thyroid Disorder Market Forecast (2019-2027)
Figure UK Thyroid Disorder Market Forecast (2019-2027)
Figure Russia Thyroid Disorder Market Forecast (2019-2027)
Figure Italy Thyroid Disorder Market Forecast (2019-2027)
Figure Rest of Europe Thyroid Disorder Market Forecast (2019-2027)
Figure Asia-Pacific Thyroid Disorder Market Forecast (2019-2027)
Figure China Thyroid Disorder Market Forecast (2019-2027)
Figure Japan Thyroid Disorder Market Forecast (2019-2027)
Figure Korea Thyroid Disorder Market Forecast (2019-2027)
Figure India Thyroid Disorder Market Forecast (2019-2027)
Figure Southeast Asia Thyroid Disorder Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Thyroid Disorder Market Forecast (2019-2027)
Figure South America Thyroid Disorder Market Forecast (2019-2027)
Figure Brazil Thyroid Disorder Market Forecast (2019-2027)
Figure Argentina Thyroid Disorder Market Forecast (2019-2027)
Figure Columbia Thyroid Disorder Market Forecast (2019-2027)
Figure Rest of South America Thyroid Disorder Market Forecast (2019-2027)
Figure Middle East and Africa Thyroid Disorder Market Forecast (2019-2027)
Figure Saudi Arabia Thyroid Disorder Market Forecast (2019-2027)
Figure United Arab Emirates Thyroid Disorder Market Forecast (2019-2027)
Figure Egypt Thyroid Disorder Market Forecast (2019-2027)
Figure Nigeria Thyroid Disorder Market Forecast (2019-2027)
Figure South Africa Thyroid Disorder Market Forecast (2019-2027)
Figure Turkey Thyroid Disorder Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Thyroid Disorder Market Forecast (2019-2027)
Figure Global Thyroid Disorder Forecast by Disorder Type (2019-2027)
Figure Global Thyroid Disorder Market Share Forecast by Disorder Type (2019-2027)
Figure Global Thyroid Disorder Forecast by Disorder Type (2019-2027)
Figure Global Thyroid Disorder Forecast by Distribution Channel (2019-2027)
Figure Global Thyroid Disorder Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Thyroid Disorder Forecast by Distribution Channel (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|